|Project Title||Updated Rivaroxaban and Severe Uterine Bleed|
The objective of this request was to investigated severe uterine bleeding (SUB) among new users of oral anticoagulants (rivaroxaban, apixaban, dabigatran, and warfarin) in the Sentinel Distributed Database (SDD). We included new users between October 19, 2010 and September 30, 2015 from 17 Data Partners contributing to the Sentinel Distributed Database (SDD) in this report. This request was distributed on September 17, 2019.
Monday, September 14, 2020
Modular Programs and Summary Tables